Home|Journals|Articles by Year|Audio Abstracts RSS - TOC

J App Pharm Sci. 2020; 10(2): 108-111

Pharmacokinetic drug–drug interaction study between clindamycin and cyclosporin in rabbits

Issam Mohammed Abushammala, Lama Attef El Gussein, Badea Elzaman Zomlot, Kamal Fakher Abushammalleh, Mohammed Mahmoud Taha, Mohammed Yousef Miqdad.


Abstract: Cyclosporine A (CSA) is an immunosuppressant drug, metabolized mainly by CYP3A4 that is one of the Cytochrome P450 enzymes. Clindamycin (CLN) is a lincosamide antibiotic, inducing CYP3A4 activity in vitro and thereby may alter CSA pharmacokinetics (PK). The current research was performed to investigate the PK parameters changes of CSA up on co-administrating with CLN in healthy male rabbits. Twelve healthy male rabbits randomly were selected and divided into two groups: Control set (n=6) in which the rabbits were received oral normal saline CSA solution (10 mg/kg/day), meanwhile rabbits in the test group (n=6) were treated with oral normal saline CSA solution (10 mg/kg/day) concomitantly with normal saline solution of CLN (8 mg/kg/day) at the same time for 7 days. Blood samples (2 mL) were collected and CSA concentrations were measured in whole blood at the predetermined time points by using Chemiluminescenct Immunoassay (CLIA) detection kit. PK profiles of CSA for both groups in the control and test groups including Cmax, tmax, AUC0-24, AUC0-∞, t½ and Ke were compared. The results showed a statistically insignificant differences in the PK parameters of CSA alone or combined with CLN with P>0.05. In conclusion, it has been found that CLN does not affect the CSA PK. Further confirmation of our findings is requiered in humans before these results can be applied in patient care.

Key words: Cyclosporine, clindamycin, drug interaction, pharmacokinetic, CYP3A4

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.